Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02358031
Brief Title: A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)

First Submitted : February 3, 2015
First Submitted that Met QC Criteria : February 3, 2015
First Posted : February 6, 2015 (Estimate)

Results First Submitted : January 29, 2020
Results First Submitted that Met QC Criteria : February 3, 2020
Results First Posted : February 17, 2020

Last Update Submitted that Met QC Criteria : October 1, 2020
Last Update Posted : October 23, 2020